Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Nakachi

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 2007
[Treatments of pancreatic cancer from the standpoint of medical oncology]Junji Furuse, Hiroshi Ishii, Kohei Nakachi, et al.
Japanese Journal of Clinical Oncology|February 3, 2007
Prognostic factors in patients with gemcitabine-refractory pancreatic cancerKohei Nakachi, Junji Furuse, Hiroshi Ishii, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 18, 2007
[Unresectable gallbladder cancer with lymph node and liver metastases completely responding to S-1 monotherapy - a case report]Junji Furuse, Kohei Nakachi, Eiichiro Suzuki, et al.
Cancer Science|October 24, 2007
Phase I study of sorafenib in Japanese patients with hepatocellular carcinomaJunji Furuse, Hiroshi Ishii, Kohei Nakachi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 25, 2010
[Chemotherapy]Masafumi Ikeda, Kohei Nakachi, Shuichi Mitsunaga, et al.
Japanese Journal of Clinical Oncology|August 20, 2023
Adjuvant and neoadjuvant chemotherapy for biliary tract cancer: a review of randomized controlled trialsKohei Nakachi, Naoto Gotohda, Etsuro Hatano, et al.
Cancer Science|October 16, 2010
Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinomaJunji Furuse, Takuji Okusaka, Shuichi Kaneko, et al.
Cancer Chemotherapy and Pharmacology|December 8, 2009
A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancerKohei Nakachi, Junji Furuse, Taira Kinoshita, et al.
Hepato-Gastroenterology|August 22, 2007
A phase I study of hypofractionated radiotherapy followed by systemic chemotherapy with full-dose gemcitabine in patients with unresectable locally advanced pancreatic cancerJunji Furuse, Hiroshi Ishii, Mitsuhiko Kawashima, et al.
Japanese Journal of Clinical Oncology|December 2, 2010
A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinomaEiichiro Suzuki, Junji Furuse, Masafumi Ikeda, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 2007
[Treatments of pancreatic cancer from the standpoint of medical oncology]Junji Furuse, Hiroshi Ishii, Kohei Nakachi, et al.
Japanese Journal of Clinical Oncology|February 3, 2007
Prognostic factors in patients with gemcitabine-refractory pancreatic cancerKohei Nakachi, Junji Furuse, Hiroshi Ishii, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 18, 2007
[Unresectable gallbladder cancer with lymph node and liver metastases completely responding to S-1 monotherapy - a case report]Junji Furuse, Kohei Nakachi, Eiichiro Suzuki, et al.
Cancer Science|October 24, 2007
Phase I study of sorafenib in Japanese patients with hepatocellular carcinomaJunji Furuse, Hiroshi Ishii, Kohei Nakachi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 25, 2010
[Chemotherapy]Masafumi Ikeda, Kohei Nakachi, Shuichi Mitsunaga, et al.
Japanese Journal of Clinical Oncology|August 20, 2023
Adjuvant and neoadjuvant chemotherapy for biliary tract cancer: a review of randomized controlled trialsKohei Nakachi, Naoto Gotohda, Etsuro Hatano, et al.
Cancer Science|October 16, 2010
Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinomaJunji Furuse, Takuji Okusaka, Shuichi Kaneko, et al.
Cancer Chemotherapy and Pharmacology|December 8, 2009
A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancerKohei Nakachi, Junji Furuse, Taira Kinoshita, et al.
Hepato-Gastroenterology|August 22, 2007
A phase I study of hypofractionated radiotherapy followed by systemic chemotherapy with full-dose gemcitabine in patients with unresectable locally advanced pancreatic cancerJunji Furuse, Hiroshi Ishii, Mitsuhiko Kawashima, et al.
Japanese Journal of Clinical Oncology|December 2, 2010
A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinomaEiichiro Suzuki, Junji Furuse, Masafumi Ikeda, et al.
Pageof 5